Status:
COMPLETED
Effects of Adherence Therapy on Medication Adherence in Patients With Schizophrenia Spectrum Disorder
Lead Sponsor:
National Yang Ming Chiao Tung University
Collaborating Sponsors:
Taipei Veterans General Hospital, Taiwan
Conditions:
Motivational Interviewing
Schizophrenia Spectrum Disorder
Eligibility:
All Genders
20-64 years
Phase:
NA
Brief Summary
This study will explore the effect of Adherence Therapy(AT) on medication adherence in patients with schizophrenia spectrum disorder.
Detailed Description
A single-blind, randomized controlled trial with a repeated-measures, two parallel groups design will be conducted for 120 participants with schizophrenia spectrum in regional hospital in northern Tai...
Eligibility Criteria
Inclusion
- aged 20-64
- were Chinese speaking or Taiwanese speaking;
- diagnosed with schizophrenia or schizoaffective disorder
- recent history of non-adherence to antipsychotic medication.
- Non-adherence to medication was defined as a recent history of cessation of psychiatric admission for more than one month at a time
- The patient recently (half year) relapse of mental illness
- Family and Health care worker state that the patient has taken irregular medication
- demonstrated cognitive understanding of the research plan and provided consent.
Exclusion
- discharged from hospital for at least 3 months
- no intellectual disability, organic brain diseases or Cognitive impairment
- no alcohol or sub-stance abuse problems
- were not attending medication management program .
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2019
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04022577
Start Date
October 1 2018
End Date
September 30 2019
Last Update
March 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Yang-Ming University
Taipei, Taiwan